The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry.
about
The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomyAdjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trialRisk assessment for prostate cancer metastasis and mortality at the time of diagnosisOutcomes of localized prostate cancer following conservative managementPost-prostatectomy incontinence: Etiology, evaluation, and managementDevelopment of South Australian-Victorian Prostate Cancer Health Outcomes Research Dataset.Robotic assistance for ultrasound-guided prostate brachytherapy.Intra-operative 3D guidance and edema detection in prostate brachytherapy using a non-isocentric C-armMagnetic resonance imaging (MRI)-guided transurethral ultrasound therapy of the prostate: a preclinical study with radiological and pathological correlation using customised MRI-based moulds.Intraoperative 3D reconstruction of prostate brachytherapy implants with automatic pose correctionImpact of folate intake on prostate cancer recurrence following definitive therapy: data from CaPSUREā¢.Development of prostate cancer research database with the clinical data warehouse technology for direct linkage with electronic medical record system.Availability and quality of paraffin blocks identified in pathology archives: a multi-institutional study by the Shared Pathology Informatics Network (SPIN).Geriatric considerations in the treatment of advanced prostate cancerRandomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09Time trends and local variation in primary treatment of localized prostate cancerSalvage radiotherapy for patients with PSA relapse following radical prostatectomy: issues and challenges.Gene expression pathways of high grade localized prostate cancer.Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancerPhysical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavorRadiosensitization of prostate cancer by priming the wild-type p53-dependent cellular senescence pathway.A systematic review of the volume-outcome relationship for radical prostatectomyTime trends in prostate cancer surgery: data from an Internet-based multicentre database.High-risk prostate cancer in the United States, 1990-2007Combining radiation therapy and androgen deprivation for localized prostate cancer-a critical review.Single positive core prostate cancer in a 12-core transrectal biopsy scheme: clinicopathological implications compared with multifocal counterpart.Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer.Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion.Contemporary trends in low risk prostate cancer: risk assessment and treatmentThe changing face of low-risk prostate cancer: trends in clinical presentation and primary management.Impact of age at diagnosis on prostate cancer treatment and survivalEarly hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrence.Androgen deprivation therapy for the treatment of prostate cancer: consider both benefits and risksImpact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer.Radiotherapy after radical prostatectomy: treatment recommendations differ between urologists and radiation oncologists.Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression.The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy.Androgen deprivation therapy and cardiovascular risk.Ionizing radiation induces neuroendocrine differentiation of prostate cancer cells in vitro, in vivo and in prostate cancer patientsImmediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse. An observational follow-up study
P2860
Q24596735-43277C1A-2145-4863-8DA9-F7839E2374B6Q24605205-7EE035C8-A798-40DF-810E-EFBBC6E68D1AQ24645292-4A3505D0-AC77-4A03-9C7B-F52AC8B07982Q24647380-447A65A5-BE4E-46B5-8EE0-6FC000318DF2Q26992305-563E6F6E-4609-48CE-99B4-985DA546873EQ30361302-2A70AA38-EF88-410D-A59F-BF2FD15C6CF1Q30393179-76440312-F52B-4AF3-B885-59FE56997F43Q30395258-FAE0E4CE-805E-4D9A-90FE-ECD7E2B56B2DQ30433561-1299EFFC-1F66-4269-BA95-C04FB98635B9Q30464864-BFB795F1-668E-496B-8A28-988374B20CBBQ30671456-815BE351-578F-44E3-97CA-E45417DD95CFQ30693970-1298DC34-AD20-49FF-900E-FB2D3E945553Q33280024-E698D783-821F-4DB7-9625-D8330933EFA4Q33598327-BD9B3D9A-861F-444B-A22E-962487E0098EQ33710935-6726E805-F45D-445E-9341-2AA354E6A86CQ33710948-5CB212EA-6D30-449E-BB9C-D1664CAA6E1FQ33766462-97EFC781-2B8E-46F7-8DA3-338D215C9BA1Q33832517-4EE6127B-67A7-4734-8FE4-4FE6C6A9A6A5Q33877542-0FD858A7-5B54-4773-8DDE-3D230C7E7F75Q33910774-BC7FC893-1288-4148-AF04-87FCB19B58F2Q33926909-6298168D-374B-4604-9CFB-93C6963062C7Q33943176-E2AB257C-A642-4A68-A90B-B2DF68EB4089Q34007634-3223E39A-4112-4E82-A5FF-C47198300787Q34168382-6835FC01-21E8-4F58-94AD-A5846B3E46A8Q34171941-D3988E5B-BBE4-4290-AC33-00FAB4552966Q34238989-A09037C4-54F1-4A27-B455-803FE5A98238Q34288796-9D6B2005-3045-4A2E-93D6-7F46C67FDB20Q34310143-0552C340-6FB6-4DCD-8AA5-C04C390158F6Q34330041-A24CF4A3-19C0-4127-894E-095291341FB2Q34380870-4D683B2C-2543-4C46-886B-7042C37C5513Q34679220-259CDEFB-C747-414A-8A0C-D6689AAFFA96Q34725046-34F42BD0-A877-4050-A340-07B821C518EAQ34960686-A26E6AB8-21E3-454B-A037-9C0BE12B867EQ34973673-944C91D8-F121-446B-ACD4-C92534CDD27FQ35041485-AB2A94CE-D853-4E9C-BBF2-C25F03034369Q35093069-F7B6F319-00E0-4C1F-BF67-5FEB1D066367Q35207309-2671441D-2EB1-4A31-83DD-DC10C3FE65C0Q35229730-C72CE6AA-763F-4EA1-9AF0-43BF7D844847Q35380936-1253FA33-BE6E-452C-8D77-B89F20C1A0E5Q35470434-AFD1F7FD-A311-4A6B-8703-C8C783139B95
P2860
The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry.
description
2004 nĆ® lÅ«n-bĆ»n
@nan
2004幓ć®č«ę
@ja
2004幓č«ę
@yue
2004幓č«ę
@zh-hant
2004幓č«ę
@zh-hk
2004幓č«ę
@zh-mo
2004幓č«ę
@zh-tw
2004幓č®ŗę
@wuu
2004幓č®ŗę
@zh
2004幓č®ŗę
@zh-cn
name
The contemporary management of ...... , a national disease registry.
@ast
The contemporary management of ...... , a national disease registry.
@en
type
label
The contemporary management of ...... , a national disease registry.
@ast
The contemporary management of ...... , a national disease registry.
@en
prefLabel
The contemporary management of ...... , a national disease registry.
@ast
The contemporary management of ...... , a national disease registry.
@en
P2093
P1476
The contemporary management of ...... , a national disease registry.
@en
P2093
CaPSURE Investigators
Deborah P Lubeck
James M Henning
Jeanette M Broering
Mark S Litwin
Peter R Carroll
Shilpa S Mehta
P304
P356
10.1097/01.JU.0000107247.81471.06
P407
P577
2004-04-01T00:00:00Z